Bisphenol A (BPA) is being recognized as an endocrinedisrupting chemical (EDC). Recently, several reports indicated that BPA affects the central nervous system (CNS) during embryonic development. However, the molecular mechanism of BPA in the CNS is not well known. Here, we show that BPA affected Notch signaling by inhibiting the activity of the Notch intracellular domain (NICD) cleavage-related enzyme, gammasecretase (g-secretase), at the neurula stage of the Xenopus laevis. BPA caused various morphologic aberrations including scoliosis, eye dysplasia, and loss of pigments in the X. laevis tadpole. These abnormalities were seen whenever BPA was used at the neurula stage. In addition, the expression levels of several marker mRNAs at the neurula stage were investigated by RT-PCR, and we found that the mRNAs expression of ectodermal marker, Pax6, CNS marker, Sox2, and neural crest marker, FoxD3, were decreased by treatment with BPA. These genes contribute to the neural differentiation at the neurula stage, and also the downstream factors of Notch signaling. Injection of NICD but not a Notch ligand, delta 1, rescued the abnormalities caused by BPA. We subsequently assayed the inhibition of the activities of NICD cleavage-related enzymes, tumor necrosis factor alpha converting enzyme, and g-secretase, by BPA and found that BPA inhibited the g-secretase activity. Furthermore, we expressed presenilin, a main component of g-secretase, in Escherichia coli and found the direct binding of BPA with presenilin. These results suggest that BPA affected the neural differentiation by inhibiting g-secretase activity, leading to neurodevelopmental abnormalities.
Bisphenol A (BPA) is widely used to produce polycarbonate plastics and is also being recognized as an endocrine-disrupting chemical (EDC) . As BPA is composed of two phenol groups which have structural homology with b-estradiol, it is suspected that it mimics estrogenic actions (Colborn et al., 1993) . Recently, nonestrogenic effects of BPA in the central nervous system (CNS) of vertebrate animals such as mice and frogs, for example, Xenopus laevis, have been reported. In the development of mice, the prenatal exposure to BPA caused the disturbance of CNS, leading to, for example, hyperactivity disorder (Nakamura et al., 2006) , and BPA induces a significant increase in the levels of dopamine D1 receptor mRNA in the brain and enhances the central dopamine D1 receptor-mediated activity (Suzuki et al., 2003) . In the early development of X. laevis, BPA induces apoptosis in the CNS (Oka et al., 2003) and causes microcephaly (Sone et al., 2004) .
Recently, to define the molecular mechanism of BPA in the CNS, protein disulfide isomerase (PDI) was isolated from rat brain as a binding protein of BPA (Hiroi et al., 2006) . PDI is an isomerase enzyme and also a multifunctional protein which acts as the b-subunit of collagen prolyl 4-hydroxylase (Vuorela et al. 1997 ), a chaperone protein producing a disulfide bond and thyroid hormone (T3)-binding protein (Primm and Gilbert, 2001) . BPA inhibits the functions of PDI including disulfide bond formation and T3-binding in vitro (Okada et al., 2005) .
The hypoxia condition is associated physiologically with cell differentiation. Hypoxia-inducible factor 1 (HIF-1) which is composed of HIF-1a and HIF-1b plays important roles in the expression of hypoxic response genes (Bernaudin et al. 2002) . Recently, we found that BPA dissociates heat shock protein 90 (HSP90) from HIF-1a and reduces the amount of HIF-1a protein in the cytoplasm of Hep3B (Kubo et al. 2004) .
Although it is reported by the studies with various vertebrate model and cells that BPA affects the CNS during the embryonic development, the mechanistic basis for effects of BPA on neurodevelopment has not yet been examined. We evaluated the effect of BPA on Notch signaling to better characterize the effects of BPA on Notch signaling though at tailbud stage of X. laevis (Imaoka et al., 2007) .
Notch signaling plays important roles in the fate decisions of undifferentiated cells. Notch signaling regulates the differentiation of the neural plate and neural crest at the neurula stage (Kuriyama et al., 2003) and also regulates mesodermal differentiation at the postneurula stage (Watanabe et al., 2006) , which corresponds to the tailbud stage and tadpole stage in amphibians and the fetus stage in humans. Notch signaling is composed of a Notch receptor and several Notch ligands including Delta, Jagged, and Serrate, which are singlepass transmembrane proteins in X. laevis (De Falco et al., 2007) . The Notch receptor interacts with the Notch ligands on the surfaces of adjacent cells. Tumor necrosis factor alpha converting enzyme (TACE) activated by the interaction digests S2 cleavage site of Notch receptor in cell membranes (Brou et al., 2000) and then c-secretase digests S3 cleavage site of Notch receptor for the release of NICD in cell membranes . NICD, after it is released, regulates ESR genes expression by acting as a coactivator of a transcription factor, suppressor of hairless, in the nucleus. The ESR genes regulate the expression of neural differentiation-related factors at the neurula stage (Foltz and Nye, 2001) .
In this study, we further characterized the molecular mechanism of BPA at the neurula stage of the X. laevis, especially the mechanism of the new target of BPA in the components of Notch signaling and the effects of the disruption of Notch signaling with BPA during embryonic development of X. laevis. We found that BPA bound to presenilin in the c-secretase components and disrupted Notch signaling by inhibiting the c-secretase activity, leading to the apoptosis and the morphologic aberrations including scoliosis, eye dysplasia and loss of pigments during the development of X. laevis embryos, as suggested by finding that have shown that this disruption of Notch signaling with BPA inhibited the differentiation of neural progenitors.
MATERIALS AND METHODS
Chemicals. Bisphenol A (2,2-bis-(4-hydroxyphenyl)-propane, BPA), Bisphenol E (4,4#-methylenebisphenol, BPE), Bisphenol F (1,1-bis (4-hydroxyphenyl)-ethane, BPF), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and O,O#-bis-(2-aminoethyl)ethyleneglycol-N,N,N#,N#-tetraacetic acid (EGTA) were purchased from Wako Pure Chemical Industry (Osaka, Japan). Dimethylbisphenol A (DMBPA) was purchased from Biomol (Plymouth Meeting, PA). N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine-tbutyl Ester (DAPT) was purchased from Peptide, Inc. (Osaka, Japan). These chemicals were dissolved in ethanol. The final concentration of ethanol was 0.01%.
Eggs and embryos of X. laevis. The unfertilized eggs of X. laevis (Watanabe Zoushoku, Hyogo, Japan) were obtained by injecting a female with 300 units of human chorionic gonadotropin (Denka Seiyaku, Kanagawa, Japan). The eggs were fertilized with the chestnuts suspended in 0.13 Modified birth's solution (0.5mM HEPES [pH 7.5] containing 10mM NaCl, 0.2mM KCl, 0.1mM MgCl 2 , and 0.2mM CaCl 2 , MBS). The chestnuts were isolated from a male through a surgical operation. The fertilized embryos were dejellied with 1% sodium thioglycollate and washed with 0.13 MBS several times. The embryos were cultured in 60-mm glass dishes with 15 ml of media (40 or 50 embryos per dish) at 14°C. The developmental stage of embryos was determined according to Nieuwkoop and Faber's normal table of X. laevis (Nieuwkoop and Faber, 1967) .
Treatment of embryos with BPA. Embryos were cultured in control media containing ethanol only (control vehicle) or the media containing 20lM BPA from st. 10.5 (early gastrula stage) to 45 (early tadpole stage). The phenotypes of embryos were observed continuously at st. 26 (early tailbud stage), st. 36 (later tailbud stage), and 45 during the development. Embryos were also cultured in the media containing various concentration of BPA (0.02, 0.04, 0.06, 0.08, 0.1, 1, 10, 20lM ) from st. 10.5 to 36, and the occurrence of abnormal development was observed at st. 36. Furthermore, embryos were treated with 20lM BPA in various periods (from st. 10.5 to st. 12.5; from st. 10.5 to st. 22; from st. 10.5 to st. 36; from st. 12.5 to st. 22; from st. 12.5 to st. 36; from st. 10.5 to st. 12 and from st. 22 to st. 36; from st. 22 to st. 36). At the end of treatment, embryos were washed with normal medium three times to remove BPA. The detailed schedule of the exposure of embryos to BPA is shown in Figure 3 . The occurrence of abnormal development was observed at st. 36. Three glass dishes containing 120 embryos (40 embryos per dish) were used in all these experiments. The media were exchanged every 12 h.
RT-PCR analysis. Embryos were cultured in control media or the media containing 20lM BPA from st. 12.5 to 22, and then the embryos were harvested at each stage (st. 12.5, 13, 14, 15, 16, 17, 18, 19, 20, 21, and 22) . Total RNA extracted from five embryos was prepared with Isogen (Wako) according to the manufacturer's instructions. cDNA was synthesized using total RNA (1 lg) in a total volume of 10 ll with MMLV reverse transcriptase (Fermentas, Burlington, Canada) according to the manufacturer's instructions as follows; incubation at 25°C for 15 min and at 42°C for 60 min followed by heating at 70°C for 10 min. PCR was performed at 94°C for 2 min and then for a number of cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s in a reaction mixture containing 10 pmol of each primer, Go taq polymerase (Promega, Madison, WI), and cDNA (100 ng). Primer sequences, accession numbers and cycles for PCR are shown in Table 1 . The PCR products were separated by electrophoresis on a 1% agarose gel, visualized with ethidium bromide staining and quantified by scanning densitometry using ImageJ software (version 1.36b; National Institutes of Health, Bethesda, MD). The relative mRNA expression levels were normalized by Histone H4.
Whole mount in situ hybridization. Albino embryos were cultured in control media or the media containing 20lM BPA from 12.5 to 18 (middle neurula stage), and then the embryos were harvested at st. 18. Thirty embryos from one dish were fixed by fully dehydrated ethanol. The antisense probes for ESR-1 were prepared from ESR-1/pCS2plus (a gift from Prof. D. L. Turn) and then generated by linearizing with Kpn I (Toyobo, Tokyo, Japan) and transcribing with T7 RNA polymerase (Roche Applied Science, Indianapolis, IN) in the presence of digoxygenin UTP (Roche). Hybridized probes were visualized according to the Roche DIG protocol with the minor alteration that 0.45 ml of NBT (75 mg/ml in dimethyl formamide) and 3.5 ml of BCIP (Roche) were added to 1 ml of AP buffer (100mM Tris-HCl [pH 9.5] containing 100mM NaCl, 50mM MgSO 4 , 0.1% Tween 20, and 25mM levamisole).
Capped mRNA synthesis and rescue experiment with microinjection. Green fluorescent protein (GFP), NICD, and Delta 1 mRNAs were prepared from GFP/ pCS2plus, NICD/pCS2plus, and Delta 1/pCS2plus (a gift from Dr C. Kinter), respectively. After the plasmids were linearized with NotI (Toyobo), capped mRNAs were made using a mCAP RNA synthesis kit (Promega) according to the manufacturer's instructions. Synthesized mRNAs (1.5 ng) were injected into each dorsal blastomere at st. 2 (two-cell stage). The embryos were cultured in control media and the media containing 20lM BPA from st. 12.5, and then the embryos were harvested at st. 18. Total RNA was isolated from the embryos for RT-PCR. To examine the phenotype of embryos, the embryos were exposed to BPA from st. 12.5 to 22 and then were harvested at st. 36.
Isolation of membrane fractions from embryos. Embryos were cultured in control media, the media containing BPA (10 or 20lM) or BPA analogs (20lM) or DAPT (20lM), respectively, from st. 12.5 to 18, and then the embryos were harvested at st. 18. Total proteins were extracted by homogenizing 300 embryos (six glass dishes, 50 embryos per dish) with a mechanical pestle-homogenizer in five volumes of ice-cold buffer A (20mM HEPES [pH 7.5] containing 50mM KCl, 2mM EGTA, and 0.1% complete protease inhibitor mixture [Roche] ). Lysates were centrifuged at 800 3 g for 10 min at 4°C to remove nuclei and large cell debris. The pellets were homogenized again and centrifuged at 800 3 g for 3 min at 4°C to remove yolk components. The supernatants were centrifuged at 100,000 3 g for 60 min REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY 345 at 4°C. The membrane pellets were washed twice in buffer A and collected by centrifugation at 100,000 3 g for 30 min at 4°C. The resulting pellets were suspended in buffer A containing 10% glycerol.
Solubilization of membrane preparations. The membrane fractions (50 lg) were suspended in buffer B (20mM HEPES [pH 7.0] containing 150mM KCl, 2mM EGTA, 1% [wt/vol] CHAPSO, and 0.1% Complete protease inhibitor mixture) and then solubilized at 4°C for 60 min by end-over-end rotation. The solubilized membranes were obtained by centrifugation at 100,000 3 g for 60 min at 4°C.
TACE-mediated peptide cleavage assay. The solubilized membrane fractions (100 lg) were incubated with 10lM intramolecularly quenched fluorogenic peptide probe (Peptide, Inc.) in buffer C (100mM Tris-HCl [pH 7.5] containing 100mM NaCl, 10mM CaCl 2 , and 0.05% Brij-35, 0.1% PEG6000) at 24°C overnight in the dark. The structure and amino acids sequence of the synthetic peptide probe were as follows; MOCAc-Lys-ProLeu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH 2 . The amyloid precursor protein (APP), which is the substrate of TACE (Camden et al. 2005) , cleavage site (underlined) that generates two peptide fractions after the action of TACE is depicted. Dnp quenches the fluorescent molecule MOCAc until cleavage occurs. C-terminal amino acid residues, alanine, and arginine residues are included to increase the solubility of the probe. After incubations, the supernatants were pooled and the fluorescence was measured using a fluorescence spectrometer with excitation wavelength at 325 nm and emission wavelength at 400 nm.
g-Secretase-mediated peptide cleavage assay. The solubilized membrane fractions (50 lg) were incubated with 10lM intramolecularly quenched fluorogenic peptide probe (Peptide, Inc.) in buffer D (50mM Tris-HCl [pH 6.8] containing 2mM EDTA and 0.25% [wt/vol] CHAPSO) at 24°C overnight in the dark. The structure and amino acids sequence of the synthetic peptide probe were as follows; Nma-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Lys(Dnp)-Arg-ArgArg-NH 2 . APP, which is also the substrate of the c-secretase (Li et al., 2007) , cleavage site (underlined) that generates two peptide fractions after the action of c-secretase is depicted. Dnp quenches the fluorescent molecule Nma until cleavage occurs. C-Terminal arginine residues are included to increase the solubility of the probe. After incubation, the supernatants were pooled and the fluorescence was measured using the fluorescence spectrometer with the excitation wavelength at 355 nm and the emission wavelength at 440 nm.
Preparation of Xenopus laevis presenilin. Presenilin cDNA (GenBank accession no. NM_001090554) was obtained by RT-PCR using specific primers. The sequences of the primers were 5#-AGGATCCGTCTGAA-GATTCCGCTGAC-3# (underline: BamHI; start codon is downstream of this primer) and 5#-ATTAAGCTTCAAGCAAACTGCCTCTTTG-3# (underline: Hind III; stop codon is upstream of this primer). PCR was performed at 94°C for 2 min and then for 32 cycles of 94°C for 30 s, 58°C for 30 s, and 68°C for 90 s in a reaction mixture containing 10 pmol of each primer, KOD polymerase (Toyobo) and cDNA (100 ng). The amplified DNA was cloned into pQE-80L vectors for protein expression in Escherichia coli (E. coli).
Surface plasmon resonance assay. His-tag fused presenilin was expressed in E. coli and purified by Ni-NTA agarose (Qiagen, Hilden, Germany). Surface plasmon resonance assay was performed with a Biacore biosensor system 2000 (Biacore, Inc., Uppsala, Sweden). BPA-amine derivative (Hiroi et al., 2006) was immobilized on the surface of CM5 sensor chips via 50mM Nhydroxysuccinimide and 200mM N-ethyl-N#-(dimethylaminopropyl) carbodiimide according to manufacturer's instructions. The remaining N-hydroxysuccinimide groups were inactivated with 1M ethanolamine (pH 8.5). As a control of nonspecific binding, the unreacted carboxymethyl groups of a sensor chip lacking BPA were blocked with ethanolamine. As an analyte, presenilin was injected over the flow rate 10 ll/min for 2 min at 25°C. HBS-EP buffer (10mM HEPES [pH 7.4] containing 150mM NaCl, 0.005% Tween 20, and 3mM EDTA) was used as a running buffer during the assay. Dissociation was observed in running buffer without analyte. Data analyses were performed using BIA evaluation ver. 3.0 software (Biacore, Tokyo, Japan).
Isolation of genomic DNA. Embryos were cultured in control media or the media containing 20lM BPA or 20lM DAPT from st. 12.5 to 22. The embryos were harvested at st. 18 before the removal of chemicals at st. 22 and st. 36 after the removal of chemicals at st. 22. DNA was prepared by homogenizing in lysis buffer (100mM Tris-HCl [pH 7.5] containing 20mM EDTA and 1% NP-40). After centrifugation, the supernatants were pooled and incubated in 180 ll of lysis buffer containing 1% SDS and 200 lg/ml RNase A at 56°C for 2 h. Samples were incubated with Proteinase K (75 lg) at 37°C for 4 h. DNA was precipitated with 2.5 volumes of ethanol and 0.5 volumes of lysis buffer TUNEL staining assay. Embryos were cultured in control media or the media containing 20lM BPA from st. 12.5 to 22, and after a washing step the embryos were harvested at st. 36 and fixed with 3.7% formalin. Sagittal sections were cut 10 lm thick and stained with TUNEL (TdT-mediated dUTPbiotin nick end labeling) by using an In situ Cell Death Detection Kit, POD (Roche) according to manufacturer's instructions.
Statistical analysis. All data are given as mean ± SD. Statistical analysis of the data was performed by one-way ANOVA. Significances were determined by ANOVA followed by Fisher's protected least significance difference test.
RESULTS

Morphologic Aberrations of Xenopus laevis
Tadpole Caused by BPA. To investigate the effects of BPA on development of X. laevis embryos, BPA was added to the media in a final concentration of 20lM at st. 10.5, and 120 embryos were then cultured until st. 45 in the presence of BPA. The phenotypes of embryos were observed at st. 26, st. 36, and st. 45 ( Fig. 1 and Table 2 ). Most of the embryos exposed to BPA showed various morphologic aberrations. BPA caused scoliosis at st. 26 (Fig. 1F) , and morphologic aberrations 
BPA Dose Dependency of Morphologic Aberrations
To investigate the occurrence of abnormal development over a wider BPA concentration range, BPA was added to the media in various concentrations of 20nM to 20lM at st. 10.5, and then embryos were cultured until st. 36 in the presence of BPA (Table 3 ). The exposure of embryos to 60nM and higher concentrations of BPA caused morphologic aberrations. However, the slight increases in abnormal development and mortality as observed for BPA concentrations of 60nM to 1lM were not statistically significant. Significant increases in rates of abnormal development were observed for 10 and 20lM. The morphologic aberrations seen in this experiment were the same as the morphologic aberrations shown in Figure 1G . There were no differences in the spectrum of morphologic aberrations caused by different concentrations of BPA.
Specification of the Period When BPA Caused Morphologic
Aberrations To identify the stages of development that are most sensitive to BPA, BPA treatment (20lM) of embryos was initiated at different developmental stages and covered distinct developmental periods (Fig. 2) . The embryos exposed to BPA at the neurula stage exhibited the morphologic aberrations shown in Figure 1G . This result shows that the exposure of embryos to BPA at the gastrula stage or the tailbud stage did not cause morphologic aberrations, and thus the neurula stage in X. laevis is important in the induction of morphologic aberrations by BPA.
Expression of Marker mRNAs at Neurula Stage by Treatment with BPA
The mRNA expression levels of several marker genes were investigated by RT-PCR during neurula stages (Fig. 3) . Embryos were exposed to 20lM BPA from st. 12.5 to st. 22. Neurulae are composed of three germ layers, the endoderm, the mesoderm and the ectoderm. The endodermal marker, Sox17a (Shimoda et al., 2007) , the mesodermal marker, goosecoid (Umbhauer et al., 2001) , and the ectodermal marker, pax6 (Duparc et al., 2007) , were examined in this investigation Note. Observations were made for embryos at st. 45. Experimental condition is described in the legend of Figure 1 . The data represent percentages of embryos showing normal, abnormal development, and the rate of mortality. The data are shown as means ± SD (n ¼ 3). Normal 87.5 ± 3.3 50.8 ± 3.9 26.7 ± 7.6* Abnormal 10.0 ± 2.4 36.6 ± 4.1* 64.2 ± 8.6* Dead 2.5 ± 0.8 12.5 ± 0.8 9.2 ± 2.1 Note. Observations were made for embryos at st. 36. The data represent percentages of embryos showing normal, abnormal development and the rate of mortality by treatment with BPA in various concentrations. The data are shown as means ± SD (n ¼ 3). *p < 0.05 versus control.
TABLE 3 Embryotoxic Effects of Various
FIG. 2.
Determination of stage-dependent sensitivity of Xenopus embryos to BPA action. BPA was added to the media at a final concentration of 20lM, and BPA was removed from the media by washing the embryos and transferring the embryos to BPA-free media on the schedule shown above. Black and white boxes indicate periods when X. laevis embryos were cultured in the presence or absence of BPA, respectively. For each treatment group, 120 embryos were cultured until st. 36 in the presence of BPA and then the number of embryos displaying scoliosis, eye dysplasia, and loss of pigments were examined. ND, not detected.
348
BABA ET AL. (Figs. 3A-3C ). There were no alterations in mRNA expression levels except pax6 at the neurula stage as a result of treatment with BPA. The expression level of pax6 mRNA was decreased in the early and middle neurula stage by treatment with BPA. These results indicate that BPA affected the ectodermal field of the neurulae. Based on these observations, the mRNA expression levels of various ectodermal marker genes were analyzed by RT-PCR during neurula stages. The ectodermal field is composed of Closed circles and open triangles indicate the mRNA expression levels of marker genes in nontreated or BPA-treated (20lM) embryos, respectively. X. laevis embryos were treated with BPA from st. 12.5 to st. 22. Graphs (A), (B), (C), (D), (E), and (F) show the mRNA expression level of sox17a, goosecoid, pax6, XK81A, sox2, and FoxD3, respectively. The asterisks denote statistically significant differences between stage-matched embryos of the control and BPA treatment groups. The values in the graphs give the means ± SD of three experiments from different X. laevis embryos. *p < 0.05, **p < 0.01 versus control. (C) Control samples; (B) BPA-treated samples.
REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY the epidermal field and the nervous field, which is composed of the neural plate and neural crest. The epidermal marker, XK81A (Lunardi and Vignali, 2006) , the neural plate marker, Sox2 (Matsuo-Takasaki et al., 2005) , and the neural crest marker, FoxD3 (Sasai et al., 2001) , were examined in this investigation (Figs. 3D-3F ). The expression level of XK81A mRNA was not changed at the neural stage by treatment with BPA. In contrast, the expression level of Sox2 mRNA was decreased in the middle and later neurula stage and the expression level of FoxD3 mRNA was also decreased in the later neurula stage by treatment with BPA. Pax6, Sox2, and FoxD3 are known as neural markers and are known to be downstream targets of Notch signaling (Glavic et al., 2004; Kumar and Moses, 2001; Wakamatsu et al., 2004) . These results suggest that BPA treatment during neurula stages results in reduced expression of markers of neural differentiation, and that disruption of Notch signaling might provide one possible mode of BPA action to suppress pax6, sox2, and FoxD3 mRNA expression.
Effects of BPA on the Notch Signaling in Neurogenic Region at Neurula Stage
To investigate the effects of BPA on Notch signaling, the expression levels of Notch mRNA and a typical Notchresponsive factor, ESR-1 mRNA, at the neurula stage were investigated by RT-PCR (Figs. 4A and 4B ). Embryos were exposed to 20lM BPA from st. 12.5 to st. 22. Notch mRNA expression was not affected at the neurula stage by treatment with BPA. In contrast, the expression level of ESR-1 mRNA was decreased in the early and middle neurula stages, especially at st. 18, by treatment with BPA. To investigate the area affected by BPA, the expression pattern of ESR-1 mRNA at st. 18 was investigated by whole mount in situ hybridization (Fig. 4C) . Albino embryos were exposed to 20lM BPA from st. 12.5 to st. 18. ESR-1 mRNA was expressed in the neurogenic region in control embryos. In contrast, ESR-1 mRNA was strongly reduced in the neural tube region in BPA-treated embryos. These results provide further Closed circles and open triangles indicate the mRNA expression levels of marker genes in nontreated or BPA-treated (20lM) embryos, respectively. X. laevis embryos were treated with BPA from st. 12.5 to st. 22. Graphs (A) and (B) show the expression levels of Notch and ESR-1 mRNA, respectively. The asterisks denote statistically significant differences between stage-matched embryos of the control and BPA treatment groups. The values in the graph give the means ± SD of three experiments from different X. laevis embryos. *p < 0.05, **p < 0.01 versus control. The expression area of ESR-1 mRNA at st. 18, when the most remarkable difference in the expression level of ESR-1 mRNA was found by RT-PCR, was investigated by whole mount in situ hybridization (C). The area of ESR-1 mRNA expression in BPA-exposed embryos is surrounded by dashed lines.
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BABA ET AL. evidence that BPA treatment during neurula stages disrupts Notch signaling in the neurogenic region.
Morphologic Aberrations Caused by the Notch Signaling Disruption
To further evaluate the possibility that BPA effects are due to a disruption of Notch signaling, DAPT, an inhibitor of c-secretase activity (Geling et al., 2002) , was added to the media in a final concentration of 20lM at st. 12.5. Embryos were exposed to DAPT from st. 12.5 to 22 and after a washing step, embryos were further cultured in control media until st. 36 (Fig. 5) . Most of the embryos exposed to DAPT showed the same morphologic aberrations as those exposed to BPA (92.5%, 111 of 120 embryos). The ability of DAPT to phenocopy the effects of BPA on morphological development suggests that the disruption of Notch signaling as one possible mode of BPA action caused the specific morphologic aberrations. To specify the target of BPA in the components of Notch signaling, rescue experiments on the expression of ESR-1 mRNA and the morphologic aberrations were performed using the Notch ligand, Delta 1, and NICD (Fig. 6) . As a result, NICD but not Delta 1 rescued the expression of ESR-1 mRNA (Fig. 6A) . In addition, injection of NICD mRNA efficiently prevented BPA from causing morphologic aberrations including scoliosis, eye dysplasia, and loss of pigments ( Fig. 6B and Table 4 ). These results suggest that BPA effects on morphology involve a disruption of Notch signaling, and that the site of BPA interference is likely upstream of NICD formation but does not affect Delta expression. Putative targets of BPA are thus the interaction between Notch receptor and Notch ligand, TACE activity, or c-secretase activity.
Inhibition of Notch Signaling-Related Enzyme, c-Secretase, by BPA Two kinds of protease enzymes, TACE and c-secretase, are needed for the cleavage activations of Notch signaling after the interaction of Notch receptor and Notch ligands. To investigate the effects of BPA on the cleavage activations of these enzymes, the enzyme activities were measured using synthesized peptides for TACE activity and for c-secretase activity, respectively (Fig. 7) . Embryos were exposed to 10 or 20lM BPA from st. 12.5 to st. 18. First, membrane fractions isolated from embryos treated with BPA were used. Results from the TACE assay did not reveal differences between control and BPA embryos. However, a strong reduction of c-secretase activity was detected in embryos after BPA treatment. Next, BPA was added directly to the reaction system containing the FIG. 5. Phenotype of embryos by treatment with DAPT and BPA. These pictures show the phenotype of control, DAPT-exposed or BPA-exposed embryos at st. 36. X. laevis embryos were treated with 20lM DAPT and 20lM BPA from st. 12.5 to st. 22, and after a washing step, embryos were cultured until st. 36. Malformations associated with body axis, pigment, and eyes are shown.
FIG. 6.
Morphologic aberrations caused by the inhibition of Notch signaling by BPA. The experiment to recover the decreased expression of ESR-1 mRNA (A) and morphologic aberrations (B) caused by BPA was performed using Delta 1 and NICD mRNA with a microinjection device. GFP was used as an injection control. The expression levels of ESR-1 mRNA at st. 18 are shown for each treatment group (A). The percentages of malformed embryos are shown for each treatment group (B and Table 4 ). The values in the graph give the means ± SD of three experiments from different X. laevis embryos. *p < 0.01 versus GFP-injected embryos without BPA, #p < 0.05 versus GFPinjected embryos with BPA. ND, not detected. REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY 351 synthesized peptide and the membrane fraction from embryos cultured in BPA-free media (Fig. 8A) . BPA efficiently inhibited c-secretase activity. Furthermore, direct interaction of BPA with presenilin, a major component of c-secretase, was investigated by surface plasmon resonance assay (Fig. 8B) . BPA was immobilized on a sensor chip and then presenilin expressed in E. coli was injected. Presenilin interacted with BPA in dose-dependent manner.
Structural Requirement of BPA for the Inhibition of c-Secretase Activity
To study the structure requirement of BPA for the inhibition of c-secretase activity, the c-secretase activity was measured using bisphenol analogs, BPE, BPF, or DMBPA (Fig. 9 ). Embryos were exposed to 20lM BPA analogs from st. 12.5 to st. 18. As a result, it was found that BPE and BPF did not affect the c-secretase activity but DMBPA inhibited the c-secretase activity. In addition, BPE and BPF did not cause morphologic aberrations, but DMBPA caused the same morphologic aberrations as BPA (data not shown). These results indicate that the two methyl groups but not the two phenol groups of BPA were necessary for the inhibition of c-secretase activity and were important to cause abnormal development.
Induction of Apoptosis by Notch Signaling Disruption
Though it has been reported that BPA induced apoptosis, the mechanism of apoptosis remains unclear. In addition, disruption of Notch signaling is associated with induction of apoptosis in human cancer cells (Chen et al., 2007) . To examine the effects of Notch signaling disruption with BPA, genomic DNA was isolated and analyzed by electrophoresis (Fig. 10A ). Embryos were exposed to 20lM DAPT or 20lM BPA from st. 12.5 to st. 18 or st. 22. DNA ladders were detected in tailbud embryos exposed to DAPT and BPA but not in control embryos. Apoptosis induction by BPA was further confirmed by sagittal sections from control and BPA-exposed embryos by TUNEL staining (Fig. 10B ). Embryos were exposed to 20lM BPA from st. 12.5 to st. 22. Although TUNEL-positive cells were not seen anywhere in control embryos, apoptotic cells were seen in BPA-exposed embryos. These results suggest that disruption of Notch signaling by BPA leads to aberrant apoptosis in X. laevis embryos.
DISCUSSION
Exposure of X. laevis embryos to BPA at the neurula stage caused morphologic aberrations including scoliosis, loss of 
34.2 ± 6.2 29.1 ± 3.7 65.8 ± 8.6* Abnormal 0 53.3 ± 5.7 63.3 ± 5.6 21.6 ± 8.2* Dead 11.7 ± 2.9 12.5 ± 0.9 7.5 ± 2.2 9.2 ± 1.2
Note. Observations were made for embryos at st. 36. Experimental condition is described in the legend of Figure 6 . The data represent percentages of embryos showing normal, abnormal development, or the rate of mortality. The data are shown as means ± SD (n ¼ 3). *p < 0.05 versus control.
FIG. 7.
Inhibition of NICD cleavage-related enzyme, c-secretase activity by BPA. Both TACE and c-secretase activities were measured by incubating solubilized membranes with the fluorescent peptide probe (10lM) overnight at 24°C (A, B). The solubilized membranes were isolated from embryos cultured in BPA-free media and the media containing 10 and 20lM BPA or 20lM DAPT. The fluorescence was measured using the fluorophotometer with excitation wavelength at 325 nm and emission wavelength at 400 nm for TACE activity and with excitation wavelength at 355 nm and emission wavelength at 440 nm for c-secretase. Control value set at 100%. The values in the graphs give the means ± SD of three different experiments from different X. laevis embryos. *p < 0.05, **p < 0.01 versus control.
352
BABA ET AL. pigments and exserted lens. These phenomena suggest that BPA affected the differentiation of various cells in the neurulae, especially Notch signaling-mediated neural differentiation. At the neurula stage, Notch signaling plays important roles in ectodermal differentiation and induces cells to maintain the undifferentiated state and grow proliferously. The inhibition of Notch signaling may induce the unscheduled differentiation and the decreasing of undifferentiated cells, leading to apoptosis. In fact, the Notch signaling disruption induced apoptosis. This result is consistent with that of Oka et al. (2003) . The apoptosis induced by the disruption of Notch signaling with BPA is probably involved with the hypoplastic tissue in the early stage of differentiation and the ensuring changes, leading to the malformation shown in Figure 1H .
Notch signaling disruption was caused by the inhibition of c-secretase activity. c-Secretase is composed of presenilin, APH-1, nicastrin, and PEN2 (Sato et al., 2007) . In this study, we found that BPA directly interacted with presenilin. BPA probably inhibits the protein cleavage function of presenilin or the interaction between Notch and c-secretase complex, leading to the inhibition of NICD cleavage in the Notch signaling pathway and the suppression of ESR genes expression at the neurula stage. These events caused the suppression of downstream factors of Notch signaling such as Pax6, Sox2, and FoxD3 mRNA in the neurulae. BPA did not affect the expression of ESR-1 mRNA in the later neurula stage, the reason for this stage specificity is currently not known. The time difference between the inhibition of expression of Sox2 and FoxD3 and ESR-1 by BPA was due to the distinct period during transcription regulation takes place.
The CNS including the eyes is derived from the neural tube. The eyes are derived from the front head region of the neural tube. Both Pax6 and Sox2 participate in this differentiation (Callaerts et al., 2006) . The suppression of Pax6 and Sox2 mRNA expressions probably inhibits the differentiation of the neural tube, leading to the eye dysplasia such as an exserted crystal lens. The various tissues and cells including the The solubilized membranes were isolated from embryos cultured in BPA-free media. The fluorescence was measured using the fluorophotometer with excitation wavelength at 355 nm and emission wavelength at 440 nm. Control value set at 100%. The values in the graph give the means ± SD of three different experiments from different X. laevis embryos. *p < 0.05 versus control. Direct interaction of BPA with presenilin was examined by surface plasmon resonance assay (B). BPA was immobilized on a sensor chip and the binding potential of presenilin, which was expressed in E. coli and was purified, was analyzed (2, 6, and 10lM presenilin). REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY peripheral nerve system, melanocytes, and cartilage cells are derived from the neural crest (Bononi et al., 2008) . The bone structure of X. laevis is formed by cartilage derived from the neural crest. The melanocytes are also derived from only the neural crest, the presence of scanty pigments suggests that BPA affected the differentiation of the neural crest. The suppression of FoxD3 mRNA expression, which participates in the differentiation of the early neural crest, may inhibit the differentiation of the neural crest, leading to scoliosis and loss of pigment.
The effective concentrations of BPA for inducing malformations were consistent with that of Sone et al. (2004) . However, the observed morphologic aberrations were different from the results reported by Sone et al. In their study, BPA caused microcephaly including ocular dysplasia, edema, and abnormal flexture. The difference of our study from their study was the breeding temperature of X. laevis. Although X. laevis embryos were cultured in 14°C in our study, Sone et al. performed the experiments at 24°C. At the low temperatures, embryos develop slowly and the exposure period to BPA in our study is longer than that of their study. The long-term exposure of embryos to BPA over a specific period may produce a different phenotype such as edema and microcephaly. In addition, it is reported that the early difference is altered by estrogenic action (Bevan et al., 2003) . Sone et al. (2004) has reported that the phenotype of embryos exposed to estrogen (E2) is different from that of embryos exposed to BPA. Although the two phenol groups of BPA are necessary for the estrogenic actions, the two methyl groups of BPA were necessary for the inhibition of c-secretase activity. These findings and our results suggest that BPA caused the abnormal development in this study by nonestrogenic action. DMBPA as well as BPA inhibited c-secretase activity and caused the morphologic aberration. These results also suggest that the morphologic aberrations are not caused by the estrogenic action.
Notch signaling regulates many aspects of development. The studies with X. laevis are suitable to examine the effects of EDCs including BPA on embryogenesis and also applicable to examine the embryogenesis of other higher animals. There are some reports concerning the effects of BPA on humans (Ikezuki et al., 2002) . However, most of them are epidemiological studies. The detailed and direct effects of BPA on humans remain unclear. These studies will lead to the clues to increase the understanding of the various developmental effects caused by BPA in different vertebrates. 
